Amgen Announces New Data Highlighting Global Trends In Hip Fracture Incidence And Treatment

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Oct. 4, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from real-world data in Asia, Europe, Oceania, and North and South America on the temporal trends in hip fracture incidence, and in post-fracture pharmacological treatment intervention. The study, presented as a late-breaking abstract at...

Click to view original post